Sex-specific factor analysis-derived profile of neuropsychiatric symptoms predicting dementia conversion in Parkinson’s disease
Objective: Neuropsychiatric symptoms (NPS) are closely associated with cognitive decline in patients with Parkinson’s disease (PD). We investigated which baseline profile of NPS predicts the…Association of type 2 diabetes and dementia in elderly patients with Parkinson’s disease: a population-based study in Korea
Objective: This study aimed to investigate the impact of type 2 diabetes (T2DM) on the development of dementia in patients with Parkinson’s disease (PD). Background:…Cortical responses evoked by stimulation of the subthalamic nucleus for intraoperative target determination in deep brain stimulation
Objective: 1. Method development to routinely determine cortical responses evoked by stimulation of the subthalamic nucleus (STN-EP) during intraoperative electrode placement for STN deep brain…Non-motor signs in essential tremor and essential tremor-plus syndromes
Objective: To investigate the non-motor profiles of essential tremor (ET) and essential tremor-plus (ET-plus) syndromes. Background: The recently established concept of differentiating ET from ET-plus…Machine learning supervised classification study for Parkinson`s disease progression through graph-based feature selection method
Objective: The model helps neuro physicians/ neurologists to improve the PD symptoms, or therapeutic-treatment planning-procedures. Background: Artificial intelligence-based machine learning (AI-ML) supervised classification systems have…Nocturnal Polyuria in Parkinson’s Disease
Objective: To characterise the prevalence of nocturnal polyuria in a cohort of people with Parkinson’s disease (PD) with lower urinary tract symptoms. Background: Lower urinary…MRI to investigate cerebrovascular changes in Parkinson’s disease
Objective: To determine the value of MRI-derived cerebrovascular metrics and their relationship with global cognitive impairment in Parkinson’s disease (PD). Background: Cognitive impairment is a…APEG-PCL Nanoparticles Containing Rifampicin Target Dopaminergic Neurons to reduce α-synuclein aggregation
Objective: There were accumulating evidence proving that rifampicin could protect neurons from apoptosis in Parkinson's disease in-vitro model by regulating SUMO modification of α-synuclein. However,…Novel strategies based on sensory electrical stimulation to manage tremor in Parkinson’s disease. A pilot study.
Objective: Tremor can be a disabling motor symptom in patients with Parkinson´s disease (PD) and in some patients is refractory to medication. Here we present…What, when and how should the information on iRBD and risk of Parkinson’s disease and related conditions be communicated?
Objective: To investigate what, when and how patients with iRBD would like to receive information regarding the potential future implications of having iRBD, once diagnosis…
- « Previous Page
- 1
- …
- 774
- 775
- 776
- 777
- 778
- …
- 1942
- Next Page »